How about the prospect of "Mysterious veil" and moving towards science?

In the past ten years, the hottest IP in the field of anti-aging is NAD+anterior body (β-nicotinamide monocyte nucleotide, etc.). With the development of biotechnology, they have taken off the mysterious veil and moved towards life and scientificization. It is gradually popularizing to Volkswagen consumers, and it is no longer an exclusive "non -old medicine" of the rich circle.

In 2022, more than half of the NAD+anti -aging substances have not decreased, and related scientific research results are fruitful. According to statistics, studies have confirmed the gain of human body in terms of conservation of cardiovascular and cerebrovascular, virus, improving sleep quality, anti -allergic, anti -tumor, and protecting the nervous system. Human clinical trials of different scale are also carried out globally.

In July 2022, Chinese and Japanese scientists published a research report on the famous scientific research magazine "Hepatology", confirming that supplementing β-nicotinamide mononucleotides can effectively improve the anti-tumor function of NK cells.

Specifically, replenishment of β-nicotinamide mononucleotide to promote NAD+levels can improve the mitochondrial dynamic balance and metabolic capacity of NK cells (naturally kill cells), effectively inhibiting tumor growth, but it is still in the animal experiment stage.

Most of the research that improves NAD+levels can reverse aging or prevent diseases in the animal experiment, which is one of the reasons why related applications are controversial in the market. Although NAD+anti -aging substances are controversial, the scientific community has no interest in such substances. In the past two years, human clinical trials carried out in the world have been more.

On May 5 this year, the international authoritative journal "Frontier in Aging" published a shopping report on the human body clinical trial of β-nicotinamide monocyte nucleotide. The report pointed out that the intake of β-nicotinamide monocytes can significantly improve the muscle activity of the elderly, especially walking speed and grip, which provides potential treatment strategies for the elderly's muscle reduction.

As early as last year, in order to deal with aging difficulties in science, the Ministry of Science and Technology of China used the high-quality raw materials of Saiming, and launched the world's largest β-nicotinamide monocyte nucleotide human clinical trial. It is understood that the project is affiliated with the key special special specialty of "active health and aging science and technology response" projects of the Ministry of Science and Technology of China. Essence Through this experiment, the effectiveness, safety and possible toxic side effects of β-nicotamide mononucleotide can be clarified.

The raw materials used for human test must be high-quality, focusing on the recovery of cell mitochondrial anti-aging fields for many years. The raw materials and finished products have always been known for high-quality and are deeply trusted by scientific research circles. David Sinclair, a professor of cell genetics at Harvard University, was used for scientific experiments by anti -aging discovery, and published NMN's major papers in the top academic journal "Cell" in 2018.

On the market, NAD+supplemental fish dragons are mixed, and there are many brands. It really has the strength and effectiveness of hard core scientific research to ensure its safety and effectiveness. Saili Fu is one of the best. It has been sold in the US market for many years. After the mainland market, it is also favored by users, and the repurchase continues.

Saili Fu β-nicotinamide single nucleotide products have multiple safety testing reports, including the FDA filing of the United States, the President of Zhejiang Medical Sciences for 8 months, and the Hexin test report, and Zhejiang CDC for 16 months. Sexual evaluation report. Saili Fu's relevant product safety test was used as the highest safety standards by Tmall International.

In addition, the raw material of Saiki β-nicotinamide monocyte nucleotide also participated in clinical research related to the world's largest female reproductive health. At present, the trial has been registered at the US Clinical Research Center (registration number: NCT05305677). The choice of many scientific research institutions is the embodiment of the hard power of scientific research.

Ai Media Consultation data predicts that NAD+specifies will climb up to 27.013 billion yuan in 2023 with a growth rate of nearly 70.25%. The market size will be further expanded. It is also largely determined whether the industry can sustainable development, and the scientific research strength of enterprises with hard cores can be invincible in a fierce competitive market.

- END -